← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

NXGL logoNEXGEL, Inc.(NXGL)Earnings, Financials & Key Ratios

NXGL•NASDAQ
$0.62
$5M mkt cap·Price updated May 7, 2026
SectorHealthcareIndustryMedical InstrumentsSub-IndustryWound care and infection prevention
AboutNEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.Show more
  • Revenue$9M+112.5%
  • EBITDA-$3M-1.3%
  • Net Income-$3M-3.9%
  • EPS (Diluted)-0.50+10.7%
  • Gross Margin31.63%+245.8%
  • EBITDA Margin-35.38%+52.3%
  • Operating Margin-40.91%+51.9%
  • Net Margin-37.76%+51.1%
  • ROE-58.35%-18.3%
  • ROIC-43.12%-14.8%
  • Debt/Equity0.46-14.2%
  • Interest Coverage-43.88+81.1%
Technical→

NXGL Key Insights

NEXGEL, Inc. (NXGL) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Strong 5Y sales CAGR of 64.7%
  • ✓Trading at only 0.7x book value

✗Weaknesses

  • ✗Negative free cash flow
  • ✗Weak momentum: RS Rating 3 (bottom 3%)
  • ✗Shares diluted 14.8% in last year
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

NXGL Price & Volume

NEXGEL, Inc. (NXGL) stock price & volume — 10-year historical chart

Loading chart...

NXGL Growth Metrics

NEXGEL, Inc. (NXGL) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years64.69%
3 Years77.6%
TTM73.38%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM18.39%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM34.48%

Return on Capital

10 Years-150.18%
5 Years-74.54%
3 Years-38.06%
Last Year-44.65%

NXGL Peer Comparison

NEXGEL, Inc. (NXGL) competitors in Wound care and infection prevention — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
LIQT logoLIQTLiqTech International, Inc.Direct Competitor22.21M2.31-2.5913.03%-53.25%-69.97%1.17
XTLB logoXTLBXTL Biopharmaceuticals Ltd.Direct Competitor293.77K2.67-0.28-227.72%-25.53%0.03
BFRI logoBFRIBiofrontera Inc.Direct Competitor13.28M1.1411.8%-25.26%-11.39%0.59
SKIN logoSKINThe Beauty Health CompanyDirect Competitor117.92M0.91-5.69-10.02%-2.03%-9.41%6.20
DERM logoDERMJourney Medical CorporationDirect Competitor102.16M5.00-6.94-29.11%-15.49%-45.4%1.28
PRPH logoPRPHProPhase Labs, Inc.Product Competitor4.98M0.12-0.05-84.75%-38.72%-6.08%3.34
HIMS logoHIMSHims & Hers Health, Inc.Product Competitor6.63B25.6750.3259%5.47%23.73%2.07
COSM logoCOSMCosmos Health Inc.Product Competitor11.15M0.35-0.301.97%-31.01%-80.15%0.48

Compare NXGL vs Peers

NEXGEL, Inc. (NXGL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs LIQT

Most directly comparable listed peer for NXGL.

Scale Benchmark

vs MCK

Larger-name benchmark to compare NXGL against a more recognizable public peer.

Peer Set

Compare Top 5

vs LIQT, XTLB, BFRI, SKIN

NXGL Income Statement

NEXGEL, Inc. (NXGL) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24TTM
Sales/Revenue2.15M1.99M2.21M717K674K1.55M2.05M4.09M8.69M11.66M
Revenue Growth %--7.43%11.09%-67.6%-6%130.12%32.04%99.66%112.47%73.38%
Cost of Goods Sold2.27M1.84M1.7M854K965K1.54M1.79M3.71M5.94M7.2M
COGS % of Revenue105.3%92.62%76.77%119.11%143.18%99.48%87.5%90.85%68.37%-
Gross Profit
-114K▲ 0%
147K▲ 228.9%
514K▲ 249.7%
-137K▼ 126.7%
-291K▼ 112.4%
8K▲ 102.7%
256K▲ 3100.0%
374K▲ 46.1%
2.75M▲ 634.8%
4.47M▲ 0%
Gross Margin %-5.3%7.38%23.23%-19.11%-43.18%0.52%12.5%9.15%31.63%38.3%
Gross Profit Growth %-228.95%249.66%-126.65%-112.41%102.75%3100%46.09%634.76%-
Operating Expenses1.75M1.12M2.4M1.79M1.97M2.58M3.6M3.85M6.3M7.45M
OpEx % of Revenue81.32%56.02%108.54%249.23%292.14%166.22%175.98%94.18%72.54%-
Selling, General & Admin1.75M1.12M2.4M01.97M2.4M2.82M3.4M5.91M7.21M
SG&A % of Revenue81.32%56.02%108.54%-292.14%155.06%137.5%83.1%68.04%-
Research & Development0000031K367K103K78K8K
R&D % of Revenue-----2%17.92%2.52%0.9%-
Other Operating Expenses0001.79M0142K421K350K313K233K
Operating Income
-1.86M▲ 0%
-969K▲ 48.0%
-1.89M▼ 94.8%
-1.92M▼ 1.9%
-2.26M▼ 17.5%
-2.57M▼ 13.7%
-3.35M▼ 30.3%
-3.48M▼ 3.9%
-3.55M▼ 2.2%
-2.98M▲ 0%
Operating Margin %-86.62%-48.64%-85.31%-268.34%-335.31%-165.7%-163.48%-85.03%-40.91%-25.54%
Operating Income Growth %-48.02%-94.84%-1.91%-17.46%-13.72%-30.27%-3.85%-2.21%-
EBITDA-1.54M-653K-1.57M-1.86M-2.21M-2.43M-3.05M-3.03M-3.07M-2.49M
EBITDA Margin %-71.56%-32.78%-70.76%-259%-327.89%-156.8%-148.78%-74.2%-35.38%-21.35%
EBITDA Growth %-57.6%-139.82%-18.58%-19.01%-10.05%-25.29%0.43%-1.32%23.42%
D&A (Non-Cash Add-back)324K316K322K67K50K138K301K443K480K488K
EBIT-1.86M-969K-1.89M-1.92M-2.25M-2.31M-3.41M-3.17M-3.38M-2.72M
Net Interest Income0000-10K-2M-1.34M-15K-81K-68K
Interest Income0000000000
Interest Expense000010K2M1.34M15K81K68K
Other Income/Expense25K001K-4K-1.74M-1.4M289K91K190K
Pretax Income
-1.84M▲ 0%
-969K▲ 47.3%
-1.89M▼ 94.8%
-1.92M▼ 1.9%
-2.26M▼ 17.7%
-4.31M▼ 90.4%
-4.75M▼ 10.1%
-3.19M▲ 32.8%
-3.46M▼ 8.6%
-2.79M▲ 0%
Pretax Margin %-85.46%-48.64%-85.31%-268.2%-335.9%-277.89%-231.74%-77.97%-39.86%-23.91%
Income Tax-63K-16K00000006K
Effective Tax Rate %3.43%1.65%0%0%0%0%0%0%0%-0.22%
Net Income
-1.78M▲ 0%
-953K▲ 46.3%
-1.89M▼ 98.1%
-1.92M▼ 1.9%
-2.26M▼ 17.7%
-4.31M▼ 90.4%
-4.75M▼ 10.1%
-3.16M▲ 33.5%
-3.28M▼ 3.9%
-2.88M▲ 0%
Net Margin %-82.53%-47.84%-85.31%-268.2%-335.9%-277.89%-231.74%-77.21%-37.76%-24.69%
Net Income Growth %-46.34%-98.11%-1.85%-17.73%-90.37%-10.12%33.48%-3.93%18.39%
Net Income (Continuing)-1.78M-953K-1.89M-1.92M-2.26M-4.31M-4.75M-3.19M-3.46M-2.79M
Discontinued Operations0000000000
Minority Interest0000000469K325K390K
EPS (Diluted)
-0.32▲ 0%
-0.17▲ 46.9%
-0.34▼ 100.0%
-0.35▼ 2.9%
-0.41▼ 17.1%
-0.77▼ 87.8%
-0.85▼ 10.4%
-0.56▲ 34.1%
-0.50▲ 10.7%
-0.36▲ 0%
EPS Growth %-46.88%-100%-2.94%-17.14%-87.8%-10.39%34.12%10.71%34.48%
EPS (Basic)-0.32-0.17-0.34-0.35-0.41-0.77-0.85-0.56-0.50-
Diluted Shares Outstanding5.57M5.57M5.57M5.57M5.57M5.57M5.57M5.67M6.51M7.97M
Basic Shares Outstanding5.57M5.57M5.57M5.57M5.57M5.57M5.57M5.67M6.51M7.97M
Dividend Payout Ratio----------

NXGL Balance Sheet

NEXGEL, Inc. (NXGL) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24TTM
Total Current Assets257K199K361K513K363K13.93M7.5M5.05M5.11M5.6M
Cash & Short-Term Investments000261K32K13.35M6.61M2.7M1.81M938K
Cash Only000261K32K13.35M1.1M2.7M1.81M938K
Short-Term Investments0000005.51M000
Accounts Receivable74K99K34K102K73K209K222K633K933K839K
Days Sales Outstanding12.5518.145.6151.9239.5349.1839.5756.539.227
Inventory158K93K101K113K233K291K502K1.32M1.75M2.02M
Days Inventory Outstanding25.4518.421.748.388.1368.84102.25129.59107.694.29
Other Current Assets000000109K336K577K1.81M
Total Non-Current Assets1M695K378K1.38M1.89M3.06M2.85M4.9M5.87M6.02M
Property, Plant & Equipment831K522K200K1.2M1.36M2.65M2.46M3.35M3.84M4.08M
Fixed Asset Turnover2.59x3.82x11.07x0.60x0.50x0.59x0.83x1.22x2.26x3.07x
Goodwill0000311K311K311K1.13M1.13M1.13M
Intangible Assets000047K33K20K326K807K712K
Long-Term Investments0000000000
Other Non-Current Assets173K173K178K178K178K63K63K95K95K380K
Total Assets
1.26M▲ 0%
894K▼ 29.1%
739K▼ 17.3%
1.89M▲ 155.8%
2.26M▲ 19.4%
16.98M▲ 652.5%
10.36M▼ 39.0%
9.96M▼ 3.9%
10.98M▲ 10.3%
11.62M▲ 0%
Asset Turnover1.71x2.23x2.99x0.38x0.30x0.09x0.20x0.41x0.79x1.09x
Asset Growth %--29.1%-17.34%155.75%19.42%652.46%-39.02%-3.88%10.33%20.08%
Total Current Liabilities384K210K407K800K1.33M2.89M859K2.55M2.47M3.31M
Accounts Payable147K63K157K510K658K254K265K1.23M1.29M795K
Days Payables Outstanding23.6812.4633.73217.97248.8860.0853.98121.1479.3955.69
Short-Term Debt0000216K2.05M15K325K97K99K
Deferred Revenue (Current)000038K54K020K179K825K
Other Current Liabilities66K27K142K69K170K272K316K677K606K1.88M
Current Ratio0.67x0.95x0.89x0.64x0.27x4.82x8.74x1.98x2.07x2.07x
Quick Ratio0.26x0.50x0.64x0.50x0.10x4.72x8.15x1.46x1.36x1.36x
Cash Conversion Cycle14.3224.07-6.42-117.75-121.2257.9487.8464.9567.465.6
Total Non-Current Liabilities83K59K51K710K854K2.01M1.86M2.24M2.43M2.74M
Long-Term Debt0000256K266K268K513K588K515K
Capital Lease Obligations000710K598K1.74M1.59M1.73M1.84M7.57M
Deferred Tax Liabilities16K000000000
Other Non-Current Liabilities83K59K51K0000000
Total Liabilities467K269K458K1.51M2.19M4.9M2.72M4.79M4.9M6.04M
Total Debt000917K1.28M4.26M2.08M2.8M2.83M3.19M
Net Debt000656K1.25M-9.09M982K98K1.02M2.25M
Debt / Equity---2.41x17.99x0.35x0.27x0.54x0.46x0.46x
Debt / EBITDA----------1.28x
Net Debt / EBITDA----------0.90x
Interest Coverage-----226.00x-1.29x-2.51x-231.80x-43.88x-40.04x
Total Equity
794K▲ 0%
625K▼ 21.3%
281K▼ 55.0%
380K▲ 35.2%
71K▼ 81.3%
12.09M▲ 16921.1%
7.64M▼ 36.8%
5.17M▼ 32.4%
6.08M▲ 17.7%
5.58M▲ 0%
Equity Growth %--21.28%-55.04%35.23%-81.32%16921.13%-36.81%-32.36%17.69%48.16%
Book Value per Share0.140.110.050.070.012.171.370.910.930.70
Total Shareholders' Equity794K625K281K380K71K12.09M7.64M4.7M5.75M5.19M
Common Stock794K625K281K57K99K6K6K6K8K8K
Retained Earnings000-238K-2.5M-6.81M-11.56M-14.71M-18M-20.03M
Treasury Stock0000000000
Accumulated OCI0000000000
Minority Interest0000000469K325K390K

NXGL Cash Flow Statement

NEXGEL, Inc. (NXGL) cash flow — operating, investing & free cash flow history

Line itemDec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24TTM
Cash from Operations-1.32M-777K-1.54M-1.81M-1.8M-2.75M-2.99M-3.24M-3.87M-3.87M
Operating CF Margin %-61.2%-39.01%-69.77%-253%-267.21%-177.5%-146.09%-79.14%-44.51%-
Operating CF Growth %-41%-98.71%-17.49%0.72%-52.86%-8.68%-8.16%-19.5%94.33%
Net Income-1.78M-953K-1.89M-1.92M-2.26M-4.31M-4.75M-3.16M-3.28M-2.88M
Depreciation & Amortization324K316K322K67K50K113K301K443K478K487K
Stock-Based Compensation12K7K206K4K232K285K298K217K367K594K
Deferred Taxes-63K-16K002K-225K0000
Other Non-Cash Items-9K-8K-14K-1K2K1.98M1.39M-318K-260K-9K
Working Capital Changes195K-123K36K39K177K-593K-234K-421K-1.17M-643K
Change in Receivables212K-27K66K-68K29K-137K-13K-411K-300K55K
Change in Inventory46K60K-3K-12K-99K-58K-211K-760K-432K-241K
Change in Payables-35K-84K94K203K137K-405K11K968K182K-289K
Cash from Investing0-7K00-312K-269K-5.59M4.46M-775K-91K
Capital Expenditures0-7K00-312K-269K-96K-696K-443K-97K
CapEx % of Revenue-0.35%--46.29%17.34%4.69%17.02%5.1%-
Acquisitions00000096K-547K-400K0
Investments----------
Other Investing000000-96K-500K00
Cash from Financing1.32M784K1.54M2.08M1.88M16.34M-3.66M379K3.75M3.34M
Debt Issued (Net)0000514K2.98M-3.66M379K218K-152K
Equity Issued (Net)000730K1.37M13.47M003.77M3.79M
Dividends Paid0000000000
Share Repurchases0000000000
Other Financing1.32M784K1.54M1.34M0-115K00-241K-292K
Net Change in Cash
0▲ 0%
0▲ 0%
0▲ 0%
261K▲ 0%
-229K▼ 187.7%
13.32M▲ 5915.7%
-12.25M▼ 192.0%
1.6M▲ 113.1%
-893K▼ 155.8%
799K▲ 0%
Free Cash Flow
-1.32M▲ 0%
-784K▲ 40.5%
-1.54M▼ 96.9%
-1.81M▼ 17.5%
-2.11M▼ 16.5%
-3.02M▼ 43.0%
-3.09M▼ 2.2%
-3.93M▼ 27.3%
-4.31M▼ 9.6%
-2.55M▲ 0%
FCF Margin %-61.2%-39.36%-69.77%-253%-313.5%-194.84%-150.78%-96.16%-49.61%-21.84%
FCF Growth %-40.47%-96.94%-17.49%-16.48%-43.02%-2.18%-27.33%-9.61%37.15%
FCF per Share-0.24-0.14-0.28-0.33-0.38-0.54-0.55-0.69-0.66-0.66
FCF Conversion (FCF/Net Income)0.74x0.82x0.82x0.94x0.80x0.64x0.63x1.03x1.18x0.88x
Interest Paid0000000000
Taxes Paid0000000000

NXGL Key Ratios

NEXGEL, Inc. (NXGL) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric20172018201920202021202220232024TTM
Return on Equity (ROE)-134.32%-416.78%-581.85%-1003.99%-70.91%-48.13%-49.32%-58.35%-51.71%
Return on Invested Capital (ROIC)-102.43%-312.58%-219.13%-144.13%-89.34%-43.23%-37.57%-43.12%-43.12%
Gross Margin7.38%23.23%-19.11%-43.18%0.52%12.5%9.15%31.63%38.3%
Net Margin-47.84%-85.31%-268.2%-335.9%-277.89%-231.74%-77.21%-37.76%-24.69%
Debt / Equity--2.41x17.99x0.35x0.27x0.54x0.46x0.46x
Interest Coverage----226.00x-1.29x-2.51x-231.80x-43.88x-40.04x
FCF Conversion0.82x0.82x0.94x0.80x0.64x0.63x1.03x1.18x0.88x
Revenue Growth-7.43%11.09%-67.6%-6%130.12%32.04%99.66%112.47%73.38%

NXGL Frequently Asked Questions

NEXGEL, Inc. (NXGL) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

NEXGEL, Inc. (NXGL) reported $11.7M in revenue for fiscal year 2024. This represents a 442% increase from $2.2M in 2016.

NEXGEL, Inc. (NXGL) grew revenue by 112.5% over the past year. This is strong growth.

NEXGEL, Inc. (NXGL) reported a net loss of $2.9M for fiscal year 2024.

Dividend & Returns

NEXGEL, Inc. (NXGL) has a return on equity (ROE) of -58.3%. Negative ROE indicates the company is unprofitable.

NEXGEL, Inc. (NXGL) had negative free cash flow of $2.5M in fiscal year 2024, likely due to heavy capital investments.

Explore More NXGL

NEXGEL, Inc. (NXGL) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.